SIREN : 881933543
BM INNOVATIONS is a French company founded 6 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in MARSEILLE (13009), this company of category PME shows in 2022 a revenue of 46 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-08-08
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Signal structurel : résultat d'exploitation insuffisant pour couvrir les intérêts.
In summary, BM INNOVATIONS combines a growing business with positive profitability. Its financial structure is fragile, with debt above sector norms — a point to monitor. Point of attention: short-term liquidity is tight.
| Indicator | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 45 635 € | 41 400 € | 25 150 € |
| Net income | 25 701 € | 3 900 € | 11 391 € |
| EBITDA | 26 555 € | -8 137 € | 9 213 € |
| Net margin | 56.3% | 9.4% | 45.3% |
In 2022, BM INNOVATIONS achieves revenue of 46 k€. Over the period 2020-2022, the company shows strong growth with a CAGR (compound annual growth rate) of +34.7%. Vs 2021, growth of +10% (41 k€ -> 46 k€). EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 27 k€, representing 58.2% of revenue. Positive scissor effect: EBITDA margin improves by +77.8 pts, sign of improved operational efficiency. Compared with its sector, this ratio places the company among the best positioned (sector median: 7.7%). Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 26 k€, i.e. 56.3% of revenue. This profit can be retained or distributed to shareholders.
45 635 €
45 635 €
26 555 €
26 555 €
25 701 €
58.2%
The debt ratio (= Financial debt / Equity x 100) stands at 1120%. This ratio is less favorable than the sector median (26.4%) and warrants attention. Financial autonomy (= Equity / Total assets x 100) reaches 90%. Compared with its sector, this ratio places the company among the best positioned (sector median: 47.0%). Cash flow represents 56.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Compared with its sector, this ratio places the company among the best positioned (sector median: 6.6%).
1120.37%
90.2%
56.32%
0.0
In 2022, the debt ratio of BM INNOVATIONS (1120.4%) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2022, the financial autonomy of BM INNOVATIONS (90.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2022, the repayment capacity of BM INNOVATIONS (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 0.09. Alert: short-term debt exceeds current assets. Risk of payment difficulties without cash reinforcement. The interest coverage ratio (= EBIT / Interest expenses) is 0.2x. Danger: operating income does not cover interest charges, unsustainable situation.
0.09
0.21
In 2022, the liquidity ratio of BM INNOVATIONS (0.09) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2022, the interest coverage of BM INNOVATIONS (0.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 31 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 51 days. Favorable situation: supplier credit is longer than customer credit by 20 days. WCR is negative (-4011 days): operations structurally generate cash. Between 2020 and 2022, WCR improved by 4071 days of revenue, freeing up cash.
-508 392 €
31 j
51 j
0 j
-4011 j
Based on 57 transactions of similar company sales
(all years),
the value of BM INNOVATIONS is estimated at
52 476 €
(range 11 707€ - 99 720€).
With an EBITDA of 26 555€, the sector multiple of 2.5x is applied.
The price/revenue ratio is 0.23x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BM INNOVATIONS with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
Largest companies by revenue in the sector Fabrication de matériel médico-chirurgical et dentaire:
Largest companies by revenue in the department Bouches-du-Rhone:
The revenue of BM INNOVATIONS in 2022 is 46 k€.
Yes, BM INNOVATIONS generated a net profit of 26 k€ in 2022.
The headquarters of BM INNOVATIONS is located in MARSEILLE (13009), in the department Bouches-du-Rhone.
The tax return of BM INNOVATIONS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BM INNOVATIONS operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.